CN112438354A - Plant fermentation liquor and preparation method and application thereof - Google Patents
Plant fermentation liquor and preparation method and application thereof Download PDFInfo
- Publication number
- CN112438354A CN112438354A CN202011342693.4A CN202011342693A CN112438354A CN 112438354 A CN112438354 A CN 112438354A CN 202011342693 A CN202011342693 A CN 202011342693A CN 112438354 A CN112438354 A CN 112438354A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- fermentation
- group
- juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 66
- 230000004151 fermentation Effects 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 61
- 241000196324 Embryophyta Species 0.000 claims abstract description 42
- 239000003814 drug Substances 0.000 claims abstract description 38
- 239000006041 probiotic Substances 0.000 claims abstract description 23
- 235000018291 probiotics Nutrition 0.000 claims abstract description 23
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 16
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 13
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 13
- 244000288157 Passiflora edulis Species 0.000 claims abstract description 12
- 235000000370 Passiflora edulis Nutrition 0.000 claims abstract description 12
- 241000405414 Rehmannia Species 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 235000020234 walnut Nutrition 0.000 claims abstract description 12
- 240000007049 Juglans regia Species 0.000 claims abstract description 11
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000004375 Dextrin Substances 0.000 claims abstract description 8
- 229920001353 Dextrin Polymers 0.000 claims abstract description 8
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 8
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000015190 carrot juice Nutrition 0.000 claims abstract description 8
- 235000019425 dextrin Nutrition 0.000 claims abstract description 8
- 235000012907 honey Nutrition 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000811 xylitol Substances 0.000 claims abstract description 8
- 235000010447 xylitol Nutrition 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 8
- 229960002675 xylitol Drugs 0.000 claims abstract description 8
- 229940104640 chinese yam extract Drugs 0.000 claims abstract description 7
- 239000008213 purified water Substances 0.000 claims abstract description 5
- 240000006766 Cornus mas Species 0.000 claims abstract 4
- 238000010564 aerobic fermentation Methods 0.000 claims abstract 2
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 18
- 238000004321 preservation Methods 0.000 claims description 18
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 16
- 230000000529 probiotic effect Effects 0.000 claims description 11
- 235000010855 food raising agent Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 241000227129 Aconitum Species 0.000 claims description 6
- 241001608472 Bifidobacterium longum Species 0.000 claims description 6
- 244000199866 Lactobacillus casei Species 0.000 claims description 6
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 6
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 6
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 229940017800 lactobacillus casei Drugs 0.000 claims description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 6
- 239000011268 mixed slurry Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 4
- 235000002767 Daucus carota Nutrition 0.000 claims description 4
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 4
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000010411 cooking Methods 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 238000009629 microbiological culture Methods 0.000 claims description 2
- 241000142975 Cornaceae Species 0.000 claims 1
- 241000758791 Juglandaceae Species 0.000 claims 1
- 235000019985 fermented beverage Nutrition 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 15
- 239000000463 material Substances 0.000 abstract description 6
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 46
- 210000003734 kidney Anatomy 0.000 description 27
- 229940109239 creatinine Drugs 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 18
- 210000002700 urine Anatomy 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 12
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 12
- 229960002930 sirolimus Drugs 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 241000209020 Cornus Species 0.000 description 8
- 108010088751 Albumins Proteins 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 7
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 7
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229940116269 uric acid Drugs 0.000 description 7
- RYSMHWILUNYBFW-UHFFFAOYSA-N 4-amino-2-[6-(dimethylamino)purin-9-yl]-5-(hydroxymethyl)oxolan-3-ol Chemical compound C1=NC=2C(N(C)C)=NC=NC=2N1C1OC(CO)C(N)C1O RYSMHWILUNYBFW-UHFFFAOYSA-N 0.000 description 6
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 229940126680 traditional chinese medicines Drugs 0.000 description 5
- 235000002722 Dioscorea batatas Nutrition 0.000 description 4
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 4
- 240000001811 Dioscorea oppositifolia Species 0.000 description 4
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 4
- 210000000683 abdominal cavity Anatomy 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 208000017169 kidney disease Diseases 0.000 description 4
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 206010061481 Renal injury Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000037806 kidney injury Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- 235000001188 Peltandra virginica Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 210000000702 aorta abdominal Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960002327 chloral hydrate Drugs 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 229950010131 puromycin Drugs 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 241000173529 Aconitum napellus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 description 1
- 241000269335 Ambystoma laterale x Ambystoma jeffersonianum Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229940023019 aconite Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229910052564 epsomite Inorganic materials 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035936 sexual power Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a plant fermentation liquid and a preparation method and application thereof, belonging to the technical field of fermented beverages. The feed comprises the following raw materials in parts by weight: 60-80 parts of purified water, 5-10 parts of carrot juice, 1-5 parts of dried rehmannia root extract, 1-5 parts of Chinese yam extract, 1-5 parts of dogwood extract, 1-3 parts of rhizoma alismatis extract, 1-3 parts of poria cocos extract, 1-3 parts of moutan bark extract, 0.1-1 part of cassia twig extract, 0.1-1 part of radix aconiti lateralis preparata extract, 1-5 parts of walnut juice, 1-5 parts of passion fruit juice, 2-3 parts of L-arabinose, 2-3 parts of honey, 1-5 parts of resistant dextrin, 1-2 parts of xylitol and 0.1-0.3 part of edible essence. The raw materials are firstly subjected to aerobic fermentation and then anaerobic fermentation to obtain plant fermentation liquor. According to the invention, the probiotics are used for fermenting the traditional Chinese medicine, so that the utilization rate of the medicinal materials is improved, the medicine effect is improved, and the taste of the product is better.
Description
Technical Field
The invention belongs to the technical field of fermented beverages, and particularly relates to a plant fermentation liquid, and a preparation method and application thereof.
Background
Nowadays, the present society has great competitive pressure, great mental stress, tiredness, and many people have the symptoms of mental disorder, soreness and weakness of waist and knees, weakness of limbs, alopecia, amnesia, dull and lusterless complexion, which are all the manifestations of kidney deficiency. Kidney deficiency is usually caused by long-term accumulation, and can not be used for tonifying with the herbs of tonifying in the extreme so as to obtain the result promptly. The traditional Chinese medicine considers that the kidney has the functions of storing essence, governing water, governing bone, generating marrow, receiving qi and the like, particularly the function of storing essence of the kidney is closely related to the growth, development, reproduction and the like of human, so the kidney is called as the "congenital foundation".
At present, kidney tonifying products on the market have traditional kidney tonifying and body strengthening tablets, kidney tonifying and blood nourishing soup, five-seed kidney tonifying pills, kidney qi pills and other classic traditional Chinese medicine formulas, but the utilization rate of medicinal materials is low, and the taste is not good. Researches show that a certain synergistic effect exists between probiotics and traditional Chinese medicines, on one hand, the probiotics can promote the absorption and utilization of the traditional Chinese medicines, and a plurality of traditional Chinese medicines can be selectively absorbed by intestinal tracts after being processed and modified by microbial flora in digestive tracts; on the other hand, the effective chemical components of alkaloid, glycosides, volatile oil and tannin contained in the traditional Chinese medicine can sweep out obstacle for the proliferation of probiotics; the oil, resin, sugar, protein, pigment and the like provide nutrition for the probiotics, and some of the probiotics even directly promote the proliferation of microorganisms.
The prior patent CN109045105A relates to a kidney-tonifying traditional Chinese medicine composition for both food and medicine, which can be used as a medicine and food for nursing the body in life, but has poor taste and low utilization rate of medicinal materials; patent CN107019211A relates to a fermented composition of plant ferment with kidney tonifying and strengthening functions, which is suitable for industrial production and home production of various plant ferments, but further processed; patent CN107468806A relates to a kidney-tonifying traditional Chinese medicine composition, decoction and freeze-dried powder thereof, which can tonify kidney and strengthen yang and have stronger pertinence to applicable population. Aiming at the defects, the applicant focuses on research to improve the utilization rate of medicinal materials and the drug effect, so that the product has better taste.
Disclosure of Invention
Aiming at the problems of low utilization rate of medicinal materials of kidney tonifying products, poor taste and the like in the prior art, the invention provides plant fermentation liquor and a preparation method and application thereof, so as to solve the problems. According to the invention, probiotics are used for fermenting traditional Chinese medicines, so that the utilization rate of medicinal materials is improved, the drug effect is improved, and the taste of the product is better.
A plant fermentation liquid comprises the following raw materials in parts by weight: 60-80 parts of purified water, 5-10 parts of carrot juice, 1-5 parts of dried rehmannia root extract, 1-5 parts of Chinese yam extract, 1-5 parts of dogwood extract, 1-3 parts of rhizoma alismatis extract, 1-3 parts of poria cocos extract, 1-3 parts of moutan bark extract, 0.1-1 part of cassia twig extract, 0.1-1 part of radix aconiti lateralis preparata extract, 1-5 parts of walnut juice, 1-5 parts of passion fruit juice, 2-3 parts of L-arabinose, 2-3 parts of honey, 1-5 parts of resistant dextrin, 1-2 parts of xylitol and 0.1-0.3 part of edible essence.
Preferably, the feed comprises the following raw materials in parts by weight: 70 parts of purified water, 5 parts of carrot juice, 4 parts of dried rehmannia root extract, 2 parts of Chinese yam extract, 2 parts of dogwood extract, 1.5 parts of rhizoma alismatis extract, 1.5 parts of poria cocos extract, 1.5 parts of moutan bark extract, 0.5 part of cassia twig extract, 0.5 part of processed monkshood extract, 5 parts of walnut juice, 5 parts of passion fruit juice, 2 parts of L-arabinose, 2 parts of honey, 5 parts of resistant dextrin, 2 parts of xylitol and 0.3 part of edible essence.
A preparation method of plant fermentation liquor comprises the following steps:
(1) squeezing carrot, passion fruit and walnut respectively for standby, then respectively crushing dried rehmannia root, Chinese yam, dogwood, rhizoma alismatis, poria cocos, tree peony bark, cassia twig and processed monkshood, adding water 1-3 cm higher than the medicinal powder, and cooking to obtain extracts of various medicines. The aim of the step is to extract the effective medicinal components in the traditional Chinese medicine.
(2) Mixing the carrot juice, passion fruit juice, walnut juice, dried rehmannia root extract, Chinese yam extract, dogwood fruit extract, rhizoma alismatis extract, poria cocos extract, moutan bark extract, cassia twig extract and radix aconiti praeparata extract prepared in the step (1) with L-arabinose, honey, resistant dextrin, xylitol and edible essence according to parts by weight to obtain mixed slurry;
(3) conveying the mixed slurry prepared in the step (2) to a sterilization container, performing high-pressure sterilization at 120 ℃ for 30min, and then cooling to 30-40 ℃ to obtain a sterilized solution;
(4) preparing an aerobic probiotic strain into a leaven I according to the proportion that the weight part of the aerobic probiotic strain is 0.001-0.01, and the total viable count is higher than 100 hundred million/g;
(5) inoculating the starter I prepared in the step (4) into the sterilized solution prepared in the step (3), and obtaining a fermentation broth I through a fermentation process;
(6) preparing an anaerobic probiotic strain into a leavening agent II according to the proportion that the weight part of the anaerobic probiotic strain is 0.001-0.01 and the total viable count is higher than 100 hundred million/g;
(7) after the fermentation in the step (5) is finished, inoculating the leavening agent II prepared in the step (6) into the fermentation liquor I prepared in the step (5), and obtaining fermentation liquor II through the fermentation process;
(8) and (5) after the fermentation in the step (7) is finished, conveying the prepared fermentation liquor II into a high-pressure spraying wall breaking machine, setting the pressure to be 20-60 MPa, and performing pasteurization on the fermentation liquor II after wall breaking to obtain the plant fermentation liquor. The beverage of the invention is liquid and can be directly drunk.
Preferably, the aerobic probiotics in the step (4) is saccharomyces cerevisiae.
Preferably, the inoculation amount of the leavening agent I in the step (5) is 500-1000 ten thousand cfu/ml, the fermentation temperature is 37 ℃, and the fermentation time is 24 h.
Preferably, the anaerobic probiotics in step (6) at least comprise bifidobacterium lactis, and one or more of lactobacillus casei, lactobacillus plantarum and bifidobacterium longum can be used on the basis of the anaerobic probiotics.
The Bifidobacterium lactis is Bifidobacterium animalis subsp.lactis SF-B-20, is preserved in China general microbiological culture Collection center (CGMCC) with the preservation number of CGMCC No.20924, the preservation date is 2020, 10 and 20 days, and the address of a preservation institution: xilu No. 1 Hospital No. 3, Beijing, Chaoyang, North.
Preferably, the anaerobic probiotic is bifidobacterium lactis: lactobacillus casei: lactobacillus plantarum: bifidobacterium longum is a mixed bacterial agent with the ratio of 1:1:1: 1.
Preferably, the inoculation amount of the leavening agent II in the step (7) is 500-1000 ten thousand cfu/ml, the fermentation temperature is 37 ℃, and the fermentation time is 72 hours.
The traditional Chinese medicines adopted by the invention are as follows:
carrot: nature and taste: ping, sweet. Tonify liver, improve vision, clear heat and remove toxicity.
Dried rehmannia root: cold in nature and sweet in taste. Clear heat and cool blood, nourish yin, promote the production of body fluid.
Chinese yam: mild in nature and sweet in taste. Tonify spleen and stomach, promote the production of body fluid and nourish lung, tonify kidney and astringe essence.
Dogwood fruit: slightly warm in nature, sour and astringent in taste. Tonify liver and kidney, astringe and induce depletion.
Rhizoma alismatis: cold in nature, sweet and bland in flavor. Induce diuresis, clear damp-heat.
Tuckahoe, poria cocos: mild in nature, sweet and bland in flavor. Detoxication, diuresis, and joint movement.
Moutan bark: slightly cold in nature, bitter and pungent in flavor. Clearing heat and cooling blood, and promoting blood circulation for removing blood stasis.
Cassia twig: pungent and sweet in flavor and warm in nature. Relieving exterior syndrome, expelling pathogenic factors from muscles, warming meridians, activating collaterals, supporting yang to regulate qi, and calming the adverse-rising energy.
Processing monkshood: hot in nature, pungent and sweet in flavor and with strong toxicity. Reviving yang and rescuing from collapse, tonifying fire and supporting yang, dispelling cold and relieving pain.
Passion fruit: sweet in taste; an acid; the nature is mild. Clearing lung and moistening dryness; tranquilization and pain relief; and stopping dysentery.
Walnut: warm in nature and sweet in taste. Warming and invigorating lung and kidney, relieving asthma, eliminating phlegm, moistening intestine, and arresting seminal emission.
The plant fermentation liquid is applied to preparing the kidney tonifying drink.
The invention has the beneficial effects that:
(1) the raw materials selected by the plant fermentation liquid are all medicinal and edible raw materials, and the raw materials can be taken for a long time through a large number of clinical tests. The compatibility of the recipe is characterized in that yin qi is treated to activate yang, so that yang is transformed into fire slightly, and qi is generated by less fire, so as to warm and tonify kidney qi. The beverage of the invention warms and tonifies kidney qi, fixes essence and supplements marrow, strengthens body and enhances the resistance of human body.
(2) The invention is fermented by microorganism, has no toxic and harmful components, is rich in various probiotics and metabolites, effectively regulates the intestinal micro-ecology of human body, and promotes the absorption of functional components of traditional Chinese medicine.
(3) The invention is treated by low-temperature high-pressure wall breaking technology, the cell is completely exploded in a physical mode, the gene sequence of the cell and the activity of effective substances are effectively preserved, and the released effective substances are only one to three thousandths of microbial cells and are easier to be absorbed by human bodies.
Detailed Description
In order to make those skilled in the art better understand the technical solutions in the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
Bifidobacterium lactis SF-B-20 strain screening
(1) The strain source is as follows: feces of kidney deficiency patient
(2) Plate culture medium: 10.0g of beef extract, 5.0g of yeast extract powder, 10.0g of peptone, 20.0g of glucose and K2HPO42.0g, sodium acetate 5.0g, MgSO4·7H2O 0.2g,MnSO4·4H2O0.1 g, Tween 801.0 g, ammonium citrate 2.0g, agar 15.0g, and distilled water 1000 ml.
(3) Isolation of the Strain
Ten-fold gradient dilution is carried out on the sample liquid, 100 mu L of each gradient is uniformly coated on MRS solid plate culture medium, and then the sample liquid is taken out and placed in an anaerobic tank to be anaerobically cultured overnight at 37 ℃. The next day, colonies with different shapes and sizes grow on the plate, a plurality of characteristic colonies of lactic acid bacteria are selected for the second-generation streak purification treatment, the plate is subjected to anaerobic activation for 1 day to obtain a culture, and then the strain identification is carried out.
(4) Determination of 16S rRNA sequence
The 16S rRNA amplification primers used were 27F: 5'-AGAGTTTGATCMTGGCTCAG-3' and 1492R: 5'-GGTTACCTTGTTACGACTT-3' are provided. The product was commissioned for Sanger sequencing in a qualified third party laboratory. The sequence was compared to the 16 srna gene in the GenBank database using the BLAsT algorithm. BLAST analysis showed that the strain SF-B-20 is very close to Bifidobacterium lactis (99% relativity).
The result of the detection
CACCTTAGACGGCTCCCCCCACAAGGGTCGGGCCACCGGCTTCGGGTGCTACCCACTTTCATGACTTGACGGGCGGTGTGTACAAGGCCCGGGAACGCATTCACCGCGGCGTTGCTGATCCGCGATTACTAGCGACTCCGCCTTCACGCAGTCGAGTTGCAGACTGCGATCCGAACTGAGACCGGTTTTCAGCGATCCGCCCCACGTCACCGTGTCGCACCGCGTTGTACCGGCCATTGTAGCATGCGTGAAGCCCTGGACGTAAGGGGCATGATGATCTGACGTCATCCCCACCTTCCTCCGAGTTGACCCCGGCGGTCCCACATGAGTTCCCGGCATCACCCGCTGGCAACATGCGGCGAGGGTTGCGCTCGTTGCGGGACTTAACCCAACATCTCACGACACGAGCTGACGACGACCATGCACCACCTGTGAACCGGCCCCGAAGGGAAACCGTGTCTCCACGGCGATCCGGCACATGTCAAGCCCAGGTAAGGTTCTTCGCGTTGCATCGAATTAATCCGCATGCTCCGCCGCTTGTGCGGGCCCCCGTCAATTTCTTTGAGTTTTAGCCTTGCGGCCGTACTCCCCAGGCGGGATGCTTAACGCGTTGGCTCCGACACGGGACCCGTGGAAAGGGCCCCACATCCAGCATCCACCGTTTACGGCGTGGACTACCAGGGTATCTAATCCTGTTCGCTCCCCACGCTTTCGCTCCTCAGCGTCAGTGACGGCCCAGAGACCTGCCTTCGCCATTGGTGTTCTTCCCGATATCTACACATTCCACCGTTACACCGGGAATTCCAGTCTCCCCTACCGCACTCCAGCCCGCCCGTACCCGGCGCAGATCCACCGTTAGGCGATGGACTTTCACACCGGACGCGACGAACCGCCTACGAGCCCTTTACGCCCAATAAATCCGGATAACGCTCGCACCCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGGTGCTTATTCGAACAATCCACTCAACACGGCCGAAACCGTGCCTTGCCCTTGAACAAAAGCGGTTTACAACCCGAAGGCCTCCATCCCGCACGCGGCGTCGCTGCATCAGGCTTGCGCCCATTGTGCAATATTCCCCACTGCTGCCTCCCGTAGGAGTCTGGGCCGTATCTCAGTCCCAATGTGGCCGGTCACCCTCTCAGGCCGGCTACCCGTCAACGCCTTGGTGGGCCATCACCCCGCCAACAAGCTGATAGGACGCGACCCCATCCCATGCCGCAAAAGCATTTCCCACCCCACCATGCGATGGAGCGGAGCATCCGGTATTACCACCCGTTTCCAGGAGCTATTCCGGTGCACAGGGCAGGTTGGTCACGCATTACTCACCCGTTCGCCACTCTCACCC
The strain is preserved in the common microorganism center of the national microorganism culture preservation and management committee, the preservation number is CGMCC No.20924, and the preservation date is 10 months and 21 days in 2020. The address of the depository institution: the microbial research institute of western road 1 institute of Chinese academy of sciences, north jing, chaoyang district, zip code: 100101, telephone: 86-10-64807355.
Example 2
Preparation of plant fermentation broth
(1) Squeezing carrot, passion fruit and walnut respectively for standby, crushing dried rehmannia root, Chinese yam, dogwood, rhizoma alismatis, poria cocos, tree peony bark, cassia twig and processed monkshood, and adding water 1-3 cm higher than the medicinal powder respectively for cooking to prepare extracts of various medicines;
(2) mixing 5 parts of carrot juice, 5 parts of passion fruit juice, 5 parts of walnut juice, 4 parts of rehmanniae extract, 2 parts of yam extract, 2 parts of dogwood extract, 1.5 parts of rhizoma alismatis extract, 1.5 parts of poria cocos extract, 1.5 parts of moutan bark extract, 0.5 part of cassia twig extract, 0.5 part of rhizoma typhonii extract, 2 parts of L-arabinose, 2 parts of honey, 5 parts of resistant dextrin, 2 parts of xylitol and 0.3 part of edible essence according to parts by weight to obtain mixed slurry;
(3) conveying the mixed slurry prepared in the step (2) to a sterilization container, performing high-pressure sterilization at 120 ℃ for 30min, and then cooling to 30-40 ℃ to obtain a sterilized solution;
(4) preparing a saccharomyces cerevisiae strain (a commercially available strain) into a leavening agent I according to the proportion that the weight part of the saccharomyces cerevisiae strain is 0.001 part and the total viable count is higher than 100 hundred million/g;
(5) inoculating the starter I prepared in the step (4) into the sterilized solution prepared in the step (3), wherein the inoculation amount is 1000 ten thousand cfu/ml, the fermentation temperature is 37 ℃, and the fermentation time is 24 hours, so as to obtain fermentation liquor I;
(6) lactobacillus casei SF-L-12: bifidobacterium lactis SF-B-20: lactobacillus plantarum SF-L-28: 0.01 part of mixed strain of bifidobacterium longum SF-B-27: 1:1:1 by weight and the proportion that the total viable count is higher than 100 hundred million/g are prepared into a leaven II;
the lactobacillus casei SF-L-12 is preserved in the common microorganism center of the national microorganism culture preservation and management committee, the preservation number is CGMCC No.20927, and the preservation date is 10 months and 21 days in 2020. The address of the depository institution: the microbial research institute of western road 1 institute of Chinese academy of sciences, north jing, chaoyang district, zip code: 100101, telephone: 86-10-64807355;
the lactobacillus plantarum SF-L-28 is preserved in the common microorganism center of the national microorganism culture preservation and management committee, the preservation number is CGMCC No.20925, and the preservation date is 10 months and 21 days in 2020. The address of the depository institution: the microbial research institute of western road 1 institute of Chinese academy of sciences, north jing, chaoyang district, zip code: 100101, telephone: 86-10-64807355;
the bifidobacterium longum SF-B-27 is preserved in the common microorganism center of the national microorganism culture preservation and management committee, the preservation number is CGMCC No.20926, and the preservation date is 10 months and 21 days in 2020. The address of the depository institution: the microbial research institute of western road 1 institute of Chinese academy of sciences, north jing, chaoyang district, zip code: 100101, telephone: 86-10-64807355;
(7) after the fermentation in the step (5) is finished, inoculating the leavening agent II prepared in the step (6) into the fermentation liquid I prepared in the step (5), wherein the inoculation amount is 500 ten thousand cfu/ml, the fermentation temperature is 37 ℃, and the fermentation time is 72 hours, so as to obtain the fermentation liquid II;
(8) and (5) after the fermentation in the step (7) is finished, conveying the prepared fermentation liquor II into a high-pressure spraying wall breaking machine, setting the pressure to be 20MPa, and performing pasteurization on the fermentation liquor II after wall breaking to obtain the plant fermentation liquor.
Example 3
Comparative experiment on effects of plant fermentation liquid prepared in example 2 of the invention
The kidney-tonifying plant fermented beverage prepared in example 2 was compared with decoction prepared by a conventional method and fermented beverage prepared by bifidobacterium lactis HN019 on the market by the same process. The protective effect of the plant fermentation beverage and the control sample prepared by the embodiment of the invention on kidney injury is researched by preparing a kidney disease model by injecting puromycin aminonucleoside into the tail vein of an SD mouse.
Firstly, Chinese herbal medicines are decocted according to the proportion of 4 parts of dried rehmannia root, 2 parts of Chinese yam, 2 parts of dogwood, 1.5 parts of oriental waterplantain rhizome, 1.5 parts of tuckahoe, 1.5 parts of tree peony bark, 0.5 part of cassia twig and 0.5 part of processed aconite by the tradition to obtain decoction as a traditional Chinese medicine.
And then, the plant fermented beverage obtained by replacing the bifidobacterium lactis SF-B-20 with the bifidobacterium lactis HN019 by the same implementation method of the invention is used as a comparison group.
1. Experimental methods
1. SD mice were randomly divided into 5 groups: control group, model group, traditional Chinese medicine group, experimental group and comparison group, 10 of them are used. Wherein, the control group is not treated, and distilled water with the same volume is infused every day after the experiment begins; the other groups were made into renal disease models by tail vein injection of puromycin aminonucleosides. The model group was not treated with drugs after modeling, and each mouse was drenched with distilled water every day; the Chinese herbal medicine group drenches Chinese herbal medicine decoction (200mg/kg) to each mouse every day within 14 days after modeling; experimental groups the fermented plant drink prepared in example 2 (200mg/kg) was drenched to each mouse daily for 14 days after modeling; the control group drenched bifidobacterium lactis HN019 plant fermented drink (200mg/kg) to each mouse every day within 14 days after modeling; keep the other living environments of the mice consistent.
2. Urine protein creatinine ratio detection 24 hour urine from mice was collected on experiment day 13, protein quantification and urine creatinine were measured, and the urine protein creatinine ratio was calculated.
3. Carrying out biochemical index detection on each group of mice 14 days after modeling, injecting 33mg/100g chloral hydrate into the abdominal cavity of an anesthetized mouse, opening the abdominal cavity under aseptic condition, collecting blood from the abdominal aorta, standing for 2h and then centrifuging. And detecting serum creatinine, urea nitrogen, uric acid, albumin, total cholesterol and triglyceride according to the steps of the kit specification.
The experimental data are analyzed by SPSS18.0 software, and the measured data are averaged plus or minus standard deviationThe group comparisons conforming to the normal distribution were performed by one-way analysis of variance, and the abnormal distribution and the measurement data were subjected to rank test at a test level α of 0.05.
group of | Number of mice | Urinary protein creatinine ratio |
Control group | 9 | 308.09±54.89 |
Building module | 10 | 2550.15±469.75A |
Experimental group | 10 | 625.84±321.52B |
Chinese medicine | 10 | 723.45±140.36B |
Comparison group | 9 | 793.45±140.36B |
Note: a <0.05 compared to normal group; b compares P <0.05 to the modeled group.
TABLE 2 serum biochemical indices of various groups of mice
Note: a <0.05 compared to control; b <0.05 compared to the modeling group; c P <0.05 compared to experimental group.
2. Results of the experiment
1 mouse in the control group died, mainly caused death by improper operation during drug administration; the control group mice died 1, mainly under anesthesia, due to dose-failure.
Table 1 shows that the urine protein creatinine ratio of the building block group is significantly increased (P <0.05) compared to the control group; compared with the modeling group, the urine protein creatinine ratio of the traditional Chinese medicine group, the experimental group and the comparative group is obviously reduced (P is less than 0.05). The ratios of the experimental group, the traditional Chinese medicine group and the comparative group protein creatinine are not significantly different (P >0.05), but the ratio of the experimental group to the traditional Chinese medicine group and the comparative group protein creatinine is lower. The traditional Chinese medicine decoction, the plant fermented beverage and the bifidobacterium lactis HN019 plant fermented beverage can reduce the ratio of urine protein creatinine caused by puromycin amino nucleoside, and the effect of the plant fermented beverage is better.
Table 2 shows that, according to the biochemical indexes of albumin in each group, compared with the control group, the modeling group is obviously increased (P <0.05), the experimental group has no significant difference (P >0.05), and the traditional Chinese medicine group and the control group are obviously decreased (P < 0.05); compared with the modeling group, the experimental group, the traditional Chinese medicine group and the control group are obviously increased (P is less than 0.05). According to the biochemical indexes of urea nitrogen of each group, compared with a control group, the modeling group is obviously increased (P is less than 0.05), and the experimental group, the traditional Chinese medicine group and the control group have no significant difference (P is more than 0.05); compared with the modeling group, the experimental group, the traditional Chinese medicine group and the control group are obviously increased (P is less than 0.05). There was no significant difference between groups according to biochemical indices of creatinine in each group (P > 0.05). According to biochemical indexes of uric acid and total cholesterol in each group, compared with a control group, the modeling group is obviously increased (P is less than 0.05), and the experimental group, the traditional Chinese medicine group and the comparison group have no significant difference (P is more than 0.05); compared with the modeling group, the experimental group, the traditional Chinese medicine group and the comparison group are obviously reduced (P is less than 0.05). According to the biochemical indexes of triglyceride of each group, compared with a control group, the building group and the comparison group are obviously increased (P is less than 0.05), and the experimental group and the traditional Chinese medicine group have no significant difference (P is more than 0.05); compared with the modeling group, the experimental group is obviously reduced (P <0.05) and the traditional Chinese medicine group and the comparison group have no significant difference (P > 0.05). Experimental results show that the traditional Chinese medicine decoction, the plant fermented drink and the bifidobacterium lactis HN019 plant fermented drink can achieve treatment effects on reduction of albumin, increase of urea nitrogen, uric acid, total cholesterol and triglyceride in mouse serum caused by puromycin aminonucleoside, and the plant fermented drink is relatively good in treatment effect.
Example 4
Example 2 experiment of protective action of plant fermentation broth on mouse kidney
The kidney-tonifying plant fermented drink prepared by the invention is proved to have a protection effect on the kidney injury of SD mice. A nephrosis model is prepared by injecting puromycin aminonucleoside into the tail vein of an SD mouse, sirolimus is used as a positive control drug to treat, and the protective effect of the plant fermentation drink prepared by the embodiment of the invention on kidney injury is researched.
1. Experimental methods
(1) SD mice were randomly divided into 4 groups: control group, model group, sirolimus group, experimental group, 10 pieces per group. Wherein, the control group is not treated, and distilled water with the same volume is infused every day after the experiment begins; the other groups were made into renal disease models by tail vein injection of puromycin aminonucleosides. The model group was not treated with drugs after modeling, and each mouse was drenched with distilled water every day; the sirolimus group was administered sirolimus (9mg/kg) per mouse daily for 14 days after modeling; the experimental group drenches 200mg/kg of the plant fermentation drink of the invention to each mouse every day within 14 days after modeling; keep the other living environments of the mice consistent.
(2) Urine protein creatinine ratio detection 24 hour urine from mice was collected on experiment day 13, protein quantification and urine creatinine were measured, and the urine protein creatinine ratio was calculated.
(3) Carrying out biochemical index detection on each group of mice 14 days after modeling, injecting 33mg/100g chloral hydrate into the abdominal cavity of an anesthetized mouse, opening the abdominal cavity under aseptic condition, collecting blood from the abdominal aorta, standing for 2h and then centrifuging. And detecting serum creatinine, urea nitrogen, uric acid, albumin, total cholesterol and triglyceride according to the steps of the kit specification.
The experimental data are analyzed by SPSS18.0 software, and the measured data are averaged plus or minus standard deviationThe group comparisons conforming to the normal distribution were performed by one-way analysis of variance, and the abnormal distribution and the measurement data were subjected to rank test at a test level α of 0.05.
group of | Number of mice | Urinary protein creatinine ratio |
Control group | 9 | 317.09±59.89 |
Building module | 8 | 2450.25±456.25A |
Sirolimus group | 10 | 623.45±140.36B |
Experimental group | 10 | 615.84±321.52B |
Note: a <0.05 compared to normal group; b <0.05 compared to model group.
TABLE 2 serum biochemical indices of various groups of mice
Note: a <0.05 compared to normal group; b <0.05 compared to model group; c < 0.05P compared to sirolimus group.
2. Results of the experiment
The control mice died 1 and the model mice died 2, mainly under anesthesia, due to dose-failure.
As shown in table 1, the urine protein creatinine ratio of the modeling group was significantly increased (P <0.05) compared to the normal group; compared with the modeling group, the ratio of the urine protein to creatinine was significantly reduced in the sirolimus group and the experimental group (P < 0.05). Sirolimus and the plant fermented drink of the invention can reduce the urinary protein creatinine ratio caused by puromycin amino nucleoside.
As shown in Table 2, compared with the normal group, the model group mice have obviously increased urea nitrogen, uric acid, total cholesterol and triglyceride, obviously reduced albumin (P <0.05), unobvious creatinine change and no statistical significance (P > 0.05); compared with a modeling group, the sirolimus group and the experimental group are obviously reduced in urea nitrogen, uric acid, total cholesterol and triglyceride, obviously increased in albumin (P <0.05), unobvious in creatinine change and free of statistical significance (P > 0.05); the albumin in the experimental group is higher than that in the sirolimus group (P <0.05), and the uric acid level in the experimental group is lower than that in the sirolimus group (P < 0.05). Experimental results show that the plant fermented drink and sirolimus have a treatment effect on the nephropathy caused by puromycin amino nucleoside.
Example 5
The plant fermented beverage has the treatment effect on patients with kidney deficiency
1. Test members: 120 patients with kidney deficiency.
Of these patients, 60 male patients and 60 female patients were aged 30 to 58 years, and the average age was (43.5 ± 5.8) years. The symptoms of mental disorder, soreness and weakness of waist and knees, weakness of limbs, dysuria, alopecia, amnesia, dull and lusterless complexion, hyposexuality, fatigue and the like can be described, and male patients also have symptoms of impotence, premature ejaculation, female patients have irregular menstruation and the like.
2. The taking method comprises the following steps: the plant fermented drink is taken 1 time a day, 10mL each time, and 1 month is 1 course of treatment.
3. And (3) evaluating the curative effect: after the traditional Chinese medicine composition is taken for one treatment course, the effect of kidney deficiency of men and women can be recovered, the sexual activity and power of men and women can be obviously improved after the traditional Chinese medicine composition is taken for the second treatment course, and the effective rate of the traditional Chinese medicine composition for the people suffering from impotence and premature ejaculation reaches more than 98%.
The clinical curative effect tracking is that the tracking curative effect evaluation is carried out on 60 patients of men and women through the standards, and after the male takes the medicine for one month, the male feels that the waist is not acid, the head is not dim, the feet are not acid, the sleep is good, and the energy is vigorous. Female patients have good sleep, ruddy complexion and vigorous energy, and the normal state of the female patients is recovered by 98 percent after taking the medicine for one month, and the effective rate is 100 percent.
Tracking clinical curative effect: according to the comprehensive evaluation of all the male and female parties through the standards, 58 male people are cured in the treatment process of 1-2 months, 60 female people with weak sexual efficacy are cured, 59 male people are cured, and the comprehensive evaluation rate is 100%.
The test result shows that the plant fermented beverage can warm and tonify kidney qi and improve the symptoms of patients with kidney deficiency; has effects of warming and invigorating kidney qi, consolidating essence, strengthening body constitution, and enhancing body resistance.
Although the present invention has been described in detail by way of preferred embodiments, the present invention is not limited thereto. Various equivalent modifications or substitutions can be made on the embodiments of the present invention by those skilled in the art without departing from the spirit and scope of the present invention, and these modifications or substitutions are within the scope of the present invention/any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Sequence listing
<120> plant fermentation liquor and preparation method and application thereof
<141> 2020-11-25
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1378
<212> DNA
<213> 2 Ambystoma laterale x Ambystoma jeffersonianum
<400> 1
caccttagac ggctcccccc acaagggtcg ggccaccggc ttcgggtgct acccactttc 60
atgacttgac gggcggtgtg tacaaggccc gggaacgcat tcaccgcggc gttgctgatc 120
cgcgattact agcgactccg ccttcacgca gtcgagttgc agactgcgat ccgaactgag 180
accggttttc agcgatccgc cccacgtcac cgtgtcgcac cgcgttgtac cggccattgt 240
agcatgcgtg aagccctgga cgtaaggggc atgatgatct gacgtcatcc ccaccttcct 300
ccgagttgac cccggcggtc ccacatgagt tcccggcatc acccgctggc aacatgcggc 360
gagggttgcg ctcgttgcgg gacttaaccc aacatctcac gacacgagct gacgacgacc 420
atgcaccacc tgtgaaccgg ccccgaaggg aaaccgtgtc tccacggcga tccggcacat 480
gtcaagccca ggtaaggttc ttcgcgttgc atcgaattaa tccgcatgct ccgccgcttg 540
tgcgggcccc cgtcaatttc tttgagtttt agccttgcgg ccgtactccc caggcgggat 600
gcttaacgcg ttggctccga cacgggaccc gtggaaaggg ccccacatcc agcatccacc 660
gtttacggcg tggactacca gggtatctaa tcctgttcgc tccccacgct ttcgctcctc 720
agcgtcagtg acggcccaga gacctgcctt cgccattggt gttcttcccg atatctacac 780
attccaccgt tacaccggga attccagtct cccctaccgc actccagccc gcccgtaccc 840
ggcgcagatc caccgttagg cgatggactt tcacaccgga cgcgacgaac cgcctacgag 900
ccctttacgc ccaataaatc cggataacgc tcgcacccta cgtattaccg cggctgctgg 960
cacgtagtta gccggtgctt attcgaacaa tccactcaac acggccgaaa ccgtgccttg 1020
cccttgaaca aaagcggttt acaacccgaa ggcctccatc ccgcacgcgg cgtcgctgca 1080
tcaggcttgc gcccattgtg caatattccc cactgctgcc tcccgtagga gtctgggccg 1140
tatctcagtc ccaatgtggc cggtcaccct ctcaggccgg ctacccgtca acgccttggt 1200
gggccatcac cccgccaaca agctgatagg acgcgacccc atcccatgcc gcaaaagcat 1260
ttcccacccc accatgcgat ggagcggagc atccggtatt accacccgtt tccaggagct 1320
attccggtgc acagggcagg ttggtcacgc attactcacc cgttcgccac tctcaccc 1378
Claims (9)
1. A plant fermentation liquid is characterized by comprising the following raw materials in parts by weight: 60-80 parts of purified water, 5-10 parts of carrot juice, 1-5 parts of dried rehmannia root extract, 1-5 parts of Chinese yam extract, 1-5 parts of dogwood extract, 1-3 parts of rhizoma alismatis extract, 1-3 parts of poria cocos extract, 1-3 parts of moutan bark extract, 0.1-1 part of cassia twig extract, 0.1-1 part of rhizoma typhonii extract, 1-5 parts of walnut juice, 1-5 parts of passion fruit juice, 2-3 parts of L-arabinose, 2-3 parts of honey, 1-5 parts of resistant dextrin, 1-2 parts of xylitol and 0.1-0.3 part of edible essence;
carrying out aerobic fermentation on the raw materials, and then carrying out anaerobic fermentation to obtain plant fermentation liquor;
the strains used for anaerobic fermentation at least comprise bifidobacterium lactis; the Bifidobacterium lactis is Bifidobacterium animalis subsp.lactis SF-B-20, is preserved in China general microbiological culture Collection center (CGMCC) with the preservation number of CGMCC No.20924, the preservation date is 2020, 10 and 21 days, and the address of a preservation institution is as follows: xilu No. 1 Hospital No. 3, Beijing, Chaoyang, North.
2. The plant fermentation broth of claim 1, comprising the following raw materials in parts by weight: 70 parts of purified water, 5 parts of carrot juice, 4 parts of dried rehmannia root extract, 2 parts of Chinese yam extract, 2 parts of dogwood extract, 1.5 parts of rhizoma alismatis extract, 1.5 parts of poria cocos extract, 1.5 parts of moutan bark extract, 0.5 part of cassia twig extract, 0.5 part of processed monkshood extract, 5 parts of walnut juice, 5 parts of passion fruit juice, 2 parts of L-arabinose, 2 parts of honey, 5 parts of resistant dextrin, 2 parts of xylitol and 0.3 part of edible essence.
3. The preparation method of the plant fermentation liquor is characterized by comprising the following steps:
(1) squeezing carrots, passion fruits and walnuts respectively for standby, then respectively crushing dried rehmannia roots, Chinese yams, dogwoods, rhizoma alismatis, poria cocos, tree peony barks, cassia twigs and processed monkshood, and adding water 1-3 cm higher than medicinal powder for cooking to prepare extracts of various medicines;
(2) mixing the carrot juice, passion fruit juice, walnut juice, dried rehmannia root extract, Chinese yam extract, dogwood fruit extract, rhizoma alismatis extract, poria cocos extract, moutan bark extract, cassia twig extract and radix aconiti praeparata extract prepared in the step (1) with L-arabinose, honey, resistant dextrin, xylitol and edible essence according to parts by weight to obtain mixed slurry;
(3) conveying the mixed slurry prepared in the step (2) to a sterilization container, performing high-pressure sterilization at 120 ℃ for 30min, and then cooling to 30-40 ℃ to obtain a sterilized solution;
(4) preparing an aerobic probiotic strain into a leaven I according to the proportion that the weight part of the aerobic probiotic strain is 0.001-0.01, and the total viable count is higher than 100 hundred million/g;
(5) inoculating the starter I prepared in the step (4) into the sterilized solution prepared in the step (3), and obtaining a fermentation broth I through a fermentation process;
(6) preparing an anaerobic probiotic strain into a leavening agent II according to the proportion that the weight part of the anaerobic probiotic strain is 0.001-0.01 and the total viable count is higher than 100 hundred million/g;
(7) after the fermentation in the step (5) is finished, inoculating the leavening agent II prepared in the step (6) into the fermentation liquor I prepared in the step (5), and obtaining fermentation liquor II through the fermentation process;
(8) and (5) after the fermentation in the step (7) is finished, conveying the prepared fermentation liquor II into a high-pressure spraying wall breaking machine, setting the pressure to be 20-60 MPa, and performing pasteurization on the fermentation liquor II after wall breaking to obtain the plant fermentation liquor.
4. The method according to claim 3, wherein the aerobic probiotic bacteria in step (4) is Saccharomyces cerevisiae.
5. The method according to claim 3, wherein the amount of the starter culture I inoculated in the step (5) is 500 to 1000 ten thousand cfu/ml, the fermentation temperature is 37 ℃ and the fermentation time is 24 hours.
6. The preparation method according to claim 3, wherein the anaerobic probiotics in step (6) comprise one or more of Bifidobacterium lactis, Lactobacillus casei, Lactobacillus plantarum and Bifidobacterium longum.
7. The method according to any one of claims 3 or 6, wherein the anaerobic probiotic bacteria in step (6) are Bifidobacterium lactis: lactobacillus casei: lactobacillus plantarum: bifidobacterium longum is a mixed bacterial agent with the ratio of 1:1:1: 1.
8. The preparation method according to claim 3, wherein the inoculation amount of the fermentation agent II in the step (7) is 500 to 1000 ten thousand cfu/ml, the fermentation temperature is 37 ℃, and the fermentation time is 72 hours.
9. Use of the plant fermentation broth of claim 1 in the preparation of a kidney-tonifying beverage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011342693.4A CN112438354A (en) | 2020-11-25 | 2020-11-25 | Plant fermentation liquor and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011342693.4A CN112438354A (en) | 2020-11-25 | 2020-11-25 | Plant fermentation liquor and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112438354A true CN112438354A (en) | 2021-03-05 |
Family
ID=74737724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011342693.4A Pending CN112438354A (en) | 2020-11-25 | 2020-11-25 | Plant fermentation liquor and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112438354A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113444675A (en) * | 2021-09-01 | 2021-09-28 | 山东向日葵生物工程有限公司 | Lactobacillus casei SF-L-12, plant beverage thereof and application thereof in ovary maintenance |
CN114350573A (en) * | 2022-03-02 | 2022-04-15 | 山东向日葵生物工程有限公司 | Bifidobacterium preparation, fermented product for preventing and treating Alzheimer's disease and preparation method thereof |
CN115137069A (en) * | 2022-09-06 | 2022-10-04 | 山东向日葵生物工程有限公司 | Lactobacillus delbrueckii subspecies bulgaricus SF-L-18 fermented product and preparation method and application thereof |
CN116139229A (en) * | 2023-01-14 | 2023-05-23 | 陕西今正药业有限公司 | Plant product for promoting growth of height and preparation method thereof |
CN116286544A (en) * | 2023-04-14 | 2023-06-23 | 山东向日葵生物工程有限公司 | Application of lactobacillus delbrueckii subspecies bulgaricus SF-L-18 in preparation of hair loss prevention and hair quality improvement fermented product |
CN117099892A (en) * | 2023-10-20 | 2023-11-24 | 山东向日葵生物工程有限公司 | Anti-fatigue fermented beverage containing bifidobacterium lactis SF-B21 and preparation process thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09294560A (en) * | 1996-05-08 | 1997-11-18 | Morikawa Kenkoudou Kk | Vegetable fermented food material and its production |
CN108208809A (en) * | 2018-01-22 | 2018-06-29 | 斯汏克(北京)生物科技有限公司 | A kind of preparation method for Chinese herbal medicine composite enzyme drink of losing weight |
CN111631401A (en) * | 2020-06-09 | 2020-09-08 | 承德医学院 | Traditional Chinese medicine enzyme and preparation method thereof |
-
2020
- 2020-11-25 CN CN202011342693.4A patent/CN112438354A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09294560A (en) * | 1996-05-08 | 1997-11-18 | Morikawa Kenkoudou Kk | Vegetable fermented food material and its production |
CN108208809A (en) * | 2018-01-22 | 2018-06-29 | 斯汏克(北京)生物科技有限公司 | A kind of preparation method for Chinese herbal medicine composite enzyme drink of losing weight |
CN111631401A (en) * | 2020-06-09 | 2020-09-08 | 承德医学院 | Traditional Chinese medicine enzyme and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
杜冠华: "《中药材"毒"古今研究概评》", 31 December 2018 * |
苏凤哲: "《常用有毒中药的临床研究》", 31 October 2019 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113444675A (en) * | 2021-09-01 | 2021-09-28 | 山东向日葵生物工程有限公司 | Lactobacillus casei SF-L-12, plant beverage thereof and application thereof in ovary maintenance |
CN114350573A (en) * | 2022-03-02 | 2022-04-15 | 山东向日葵生物工程有限公司 | Bifidobacterium preparation, fermented product for preventing and treating Alzheimer's disease and preparation method thereof |
CN115137069A (en) * | 2022-09-06 | 2022-10-04 | 山东向日葵生物工程有限公司 | Lactobacillus delbrueckii subspecies bulgaricus SF-L-18 fermented product and preparation method and application thereof |
CN116139229A (en) * | 2023-01-14 | 2023-05-23 | 陕西今正药业有限公司 | Plant product for promoting growth of height and preparation method thereof |
CN116139229B (en) * | 2023-01-14 | 2024-03-01 | 陕西今正药业有限公司 | Plant product for promoting growth of height and preparation method thereof |
CN116286544A (en) * | 2023-04-14 | 2023-06-23 | 山东向日葵生物工程有限公司 | Application of lactobacillus delbrueckii subspecies bulgaricus SF-L-18 in preparation of hair loss prevention and hair quality improvement fermented product |
CN117099892A (en) * | 2023-10-20 | 2023-11-24 | 山东向日葵生物工程有限公司 | Anti-fatigue fermented beverage containing bifidobacterium lactis SF-B21 and preparation process thereof |
CN117099892B (en) * | 2023-10-20 | 2023-12-22 | 山东向日葵生物工程有限公司 | Anti-fatigue fermented beverage containing bifidobacterium lactis SF-B21 and preparation process thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112438354A (en) | Plant fermentation liquor and preparation method and application thereof | |
CN103393121B (en) | Preparation method of enzyme-containing compound probiotic plant ferment able to improve gastrointestinal functions | |
CN108685094B (en) | Traditional Chinese medicine enzyme and preparation method thereof | |
CN102934809B (en) | Composition prepared by probiotic-fermented traditional Chinese medicine (TCM) preparation as well as preparation method and application of compound | |
CN113647633B (en) | Lactobacillus plantarum SF-L-28 plant beverage capable of protecting liver and reducing lipid and preparation process thereof | |
CN113908251B (en) | Traditional Chinese medicine composition for improving immunity, traditional Chinese medicine fermented yoghourt and preparation method thereof | |
CN105249109A (en) | Preparation method of composite-probiotics-enriched plant enzymes drink capable of improving gastrointestinal function of child | |
CN111329055B (en) | Preparation method of trifoliate acanthopanax enzyme | |
CN114908020A (en) | Lactobacillus plantarum for resisting helicobacter pylori infection and application of lactobacillus plantarum in edible herbal enzyme product | |
CN115137069A (en) | Lactobacillus delbrueckii subspecies bulgaricus SF-L-18 fermented product and preparation method and application thereof | |
CN104304589A (en) | Herba dendrodii of cinalis kombucha | |
CN114041593A (en) | Uric acid-reducing composite oligosaccharide enzyme and preparation method thereof | |
CN112075626A (en) | Traditional Chinese medicine fermented beverage for tonifying qi and enriching blood and using method and preparation method thereof | |
CN113455602A (en) | Plant enzyme peptide beverage and preparation method thereof | |
CN109966427A (en) | A kind of fermentation living bacterial liquid and preparation method thereof treated tumour and improve immunity of organisms | |
CN102133283A (en) | Medicine for treating constipation and preparation method thereof | |
CN1284848C (en) | Dry red persimmon wine and its brewing method | |
CN104146201A (en) | Total nutrient formulation food for patients with rheumatoid arthritis | |
CN117085086B (en) | Qi and blood tonifying ferment and preparation process and application thereof | |
CN109965141A (en) | A kind of sea cucumber bait additive of the probiotic bacteria culture medium containing active Chinese drug component | |
CN113144127A (en) | Intelligence-promoting enzyme with anti-inflammatory and/or anti-dementia functions and preparation method thereof | |
CN116965540A (en) | A health product prepared from Chinese medicinal materials for relieving hangover and protecting liver, and its preparation method | |
CN117503834A (en) | Stomach-invigorating digestion-promoting traditional Chinese medicine fermentation preparation and preparation method thereof | |
CN111838460A (en) | Chinese herbal medicine feed additive used for piglet stage and preparation method thereof | |
CN117695366A (en) | Liver cancer-resistant traditional Chinese medicine ferment and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210305 |